PLCG1 and neoplasm: Intriguingly, at the nucleotide level, the PLCG1 hotspot Ser345 is altered in the three affected tumor samples in two different ways (c.1034C>T vs. c.1034_1035delinsTT), both resulting in the same amino acid exchange (p.Ser345Phe) with known oncogenic properties [25].